Literature DB >> 31591088

Depot contraception and HIV: an exercise in obfuscation.

C Sathyamala1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31591088     DOI： 10.1136/bmj.l5768

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity.

Authors:  Xiangxu Jia; Qiujia Shao; Ahsen R Chaudhry; Ballington L Kinlock; Michael G Izban; Hong-Ying Zhang; Fernando Villalta; James E K Hildreth; Bindong Liu
Journal:  Pathogens       Date:  2021-09-14

2.  Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Mike Gaskins; Elvis I Seman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-01-27

3.  Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.

Authors:  Jennifer A Smith; Leo Beacroft; Fareed Abdullah; Buyile Buthelezi; Manala Makua; Chelsea Morroni; Gita Ramjee; Claudia Velasquez; Timothy B Hallett
Journal:  J Int AIDS Soc       Date:  2020-10       Impact factor: 5.396

4.  Regular Use of Depot Medroxyprogesterone Acetate Causes Thinning of the Superficial Lining and Apical Distribution of Human Immunodeficiency Virus Target Cells in the Human Ectocervix.

Authors:  Gabriella Edfeldt; Julie Lajoie; Maria Röhl; Julius Oyugi; Alexandra Åhlberg; Behnaz Khalilzadeh-Binicy; Frideborg Bradley; Matthias Mack; Joshua Kimani; Kenneth Omollo; Carolina Wählby; Keith R Fowke; Kristina Broliden; Annelie Tjernlund
Journal:  J Infect Dis       Date:  2022-04-01       Impact factor: 5.226

5.  Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.

Authors:  Janet P Hapgood
Journal:  AIDS Res Hum Retroviruses       Date:  2020-01-22       Impact factor: 2.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.